Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1999 Mar;8(3):467–481. doi: 10.1110/ps.8.3.467

Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate.

V I Polshakov 1, B Birdsall 1, T A Frenkiel 1, A R Gargaro 1, J Feeney 1
PMCID: PMC2144292  PMID: 10091649

Abstract

We have determined the three-dimensional solution structure of the complex of Lactobacillus casei dihydrofolate reductase and the anticancer drug trimetrexate. Two thousand seventy distance, 345 dihedral angle, and 144 hydrogen bond restraints were obtained from analysis of multidimensional NMR spectra recorded for complexes containing 15N-labeled protein. Simulated annealing calculations produced a family of 22 structures fully consistent with the constraints. Several intermolecular protein-ligand NOEs were obtained by using a novel approach monitoring temperature effects of NOE signals resulting from dynamic processes in the bound ligand. At low temperature (5 degrees C) the trimethoxy ring of bound trimetrexate is flipping sufficiently slowly to give narrow signals in slow exchange, which give good NOE cross peaks. At higher temperature these broaden and their NOE cross peaks disappear thus allowing the signals in the lower-temperature spectrum to be identified as NOEs involving ligand protons. The binding site for trimetrexate is well defined and this was compared with the binding sites in related complexes formed with methotrexate and trimethoprim. No major conformational differences were detected between the different complexes. The 2,4-diaminopyrimidine-containing moieties in the three drugs bind essentially in the same binding pocket and the remaining parts of their molecules adapt their conformations such that they can make effective van der Waals interactions with essentially the same set of hydrophobic amino acids, the side-chain orientations and local conformations of which are not greatly changed in the different complexes (similar chi1 and chi2 values).

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews J., Clore G. M., Davies R. W., Gronenborn A. M., Gronenborn B., Kalderon D., Papadopoulos P. C., Schäfer S., Sims P. F., Stancombe R. Nucleotide sequence of the dihydrofolate reductase gene of methotrexate-resistant Lactobacillus casei. Gene. 1985;35(1-2):217–222. doi: 10.1016/0378-1119(85)90174-x. [DOI] [PubMed] [Google Scholar]
  2. Antonjuk D. J., Birdsall B., Cheung H. T., Clore G. M., Feeney J., Gronenborn A., Roberts G. C., Tran T. Q. A 1H n.m.r. study of the role of the glutamate moiety in the binding of methotrexate to Lactobacillus casei dihydrofolate reductase. Br J Pharmacol. 1984 Feb;81(2):309–315. doi: 10.1111/j.1476-5381.1984.tb10080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baccanari D. P., Kuyper L. F. Basis of selectivity of antibacterial diaminopyrimidines. J Chemother. 1993 Dec;5(6):393–399. [PubMed] [Google Scholar]
  4. Bertino J. R., Sawicki W. L., Moroson B. A., Cashmore A. R., Elslager E. F. 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo. Biochem Pharmacol. 1979 Jun 15;28(12):1983–1987. doi: 10.1016/0006-2952(79)90655-5. [DOI] [PubMed] [Google Scholar]
  5. Bevan A. W., Roberts G. C., Feeney J., Kuyper L. 1H and 15N NMR studies of protonation and hydrogen-bonding in the binding of trimethoprim to dihydrofolate reductase. Eur Biophys J. 1985;11(4):211–218. doi: 10.1007/BF00261997. [DOI] [PubMed] [Google Scholar]
  6. Birdsall B., Andrews J., Ostler G., Tendler S. J., Feeney J., Roberts G. C., Davies R. W., Cheung H. T. NMR studies of differences in the conformations and dynamics of ligand complexes formed with mutant dihydrofolate reductases. Biochemistry. 1989 Feb 7;28(3):1353–1362. doi: 10.1021/bi00429a062. [DOI] [PubMed] [Google Scholar]
  7. Birdsall B., Burgen A. S., Hyde E. I., Roberts G. C., Feeney J. Negative cooperativity between folinic acid and coenzyme in their binding to Lactobacillus casei dihydrofolate reductase. Biochemistry. 1981 Dec 8;20(25):7186–7195. doi: 10.1021/bi00528a021. [DOI] [PubMed] [Google Scholar]
  8. Birdsall B., Burgen A. S., Roberts G. C. Binding of coenzyme analogues to Lactobacillus casei dihydrofolate reductase: binary and ternary complexes. Biochemistry. 1980 Aug 5;19(16):3723–3731. doi: 10.1021/bi00557a013. [DOI] [PubMed] [Google Scholar]
  9. Birdsall B., Casarotto M. G., Cheung H. T., Basran J., Roberts G. C., Feeney J. The influence of aspartate 26 on the tautomeric forms of folate bound to Lactobacillus casei dihydrofolate reductase. FEBS Lett. 1997 Feb 3;402(2-3):157–161. doi: 10.1016/s0014-5793(96)01519-0. [DOI] [PubMed] [Google Scholar]
  10. Birdsall B., Feeney J., Pascual C., Roberts G. C., Kompis I., Then R. L., Müller K., Kroehn A. A 1H NMR study of the interactions and conformations of rationally designed brodimoprim analogues in complexes with Lactobacillus casei dihydrofolate reductase. J Med Chem. 1984 Dec;27(12):1672–1676. doi: 10.1021/jm00378a025. [DOI] [PubMed] [Google Scholar]
  11. Birdsall B., Feeney J., Tendler S. J., Hammond S. J., Roberts G. C. Dihydrofolate reductase: multiple conformations and alternative modes of substrate binding. Biochemistry. 1989 Mar 7;28(5):2297–2305. doi: 10.1021/bi00431a048. [DOI] [PubMed] [Google Scholar]
  12. Birdsall B., Gronenborn A., Hyde E. I., Clore G. M., Roberts G. C., Feeney J., Burgen A. S. Hydrogen-1, carbon-13, and phosphorus-31 nuclear magnetic resonance studies of the dihydrofolate reductase-nicotinamide adenine dinucleotide phosphate-folate complex: characterization of three coexisting conformational states. Biochemistry. 1982 Nov 9;21(23):5831–5838. doi: 10.1021/bi00266a017. [DOI] [PubMed] [Google Scholar]
  13. Birdsall B., Tendler S. J., Arnold J. R., Feeney J., Griffin R. J., Carr M. D., Thomas J. A., Roberts G. C., Stevens M. F. NMR studies of multiple conformations in complexes of Lactobacillus casei dihydrofolate reductase with analogues of pyrimethamine. Biochemistry. 1990 Oct 16;29(41):9660–9667. doi: 10.1021/bi00493a022. [DOI] [PubMed] [Google Scholar]
  14. Bolin J. T., Filman D. J., Matthews D. A., Hamlin R. C., Kraut J. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. J Biol Chem. 1982 Nov 25;257(22):13650–13662. [PubMed] [Google Scholar]
  15. Carr M. D., Birdsall B., Frenkiel T. A., Bauer C. J., Jimenez-Barbero J., Polshakov V. I., McCormick J. E., Roberts G. C., Feeney J. Dihydrofolate reductase: sequential resonance assignments using 2D and 3D NMR and secondary structure determination in solution. Biochemistry. 1991 Jun 25;30(25):6330–6341. doi: 10.1021/bi00239a035. [DOI] [PubMed] [Google Scholar]
  16. Cheung H. T., Birdsall B., Frenkiel T. A., Chau D. D., Feeney J. 13C NMR determination of the tautomeric and ionization states of folate in its complexes with Lactobacillus casei dihydrofolate reductase. Biochemistry. 1993 Jul 13;32(27):6846–6854. doi: 10.1021/bi00078a007. [DOI] [PubMed] [Google Scholar]
  17. Clore G. M., Driscoll P. C., Wingfield P. T., Gronenborn A. M. Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. Biochemistry. 1990 Aug 14;29(32):7387–7401. doi: 10.1021/bi00484a006. [DOI] [PubMed] [Google Scholar]
  18. Clore G. M., Gronenborn A. M., Birdsall B., Feeney J., Roberts G. C. 19F-n.m.r. studies of 3',5'-difluoromethotrexate binding to Lactobacillus casei dihydrofolate reductase. Molecular motion and coenzyme-induced conformational changes. Biochem J. 1984 Feb 1;217(3):659–666. doi: 10.1042/bj2170659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cocco L., Roth B., Temple C., Jr, Montgomery J. A., London R. E., Blakley R. L. Protonated state of methotrexate, trimethoprim, and pyrimethamine bound to dihydrofolate reductase. Arch Biochem Biophys. 1983 Oct 15;226(2):567–577. doi: 10.1016/0003-9861(83)90326-0. [DOI] [PubMed] [Google Scholar]
  20. Dann J. G., Ostler G., Bjur R. A., King R. W., Scudder P., Turner P. C., Roberts G. C., Burgen A. S. Large-scale purification and characterization of dihydrofolate reductase from a methotrexate-resistant strain of Lactobacillus casei. Biochem J. 1976 Sep 1;157(3):559–571. doi: 10.1042/bj1570559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Elslager E. F., Johnson J. L., Werbel L. M. Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines. J Med Chem. 1983 Dec;26(12):1753–1760. doi: 10.1021/jm00366a018. [DOI] [PubMed] [Google Scholar]
  22. Epstein D. M., Benkovic S. J., Wright P. E. Dynamics of the dihydrofolate reductase-folate complex: catalytic sites and regions known to undergo conformational change exhibit diverse dynamical features. Biochemistry. 1995 Sep 5;34(35):11037–11048. doi: 10.1021/bi00035a009. [DOI] [PubMed] [Google Scholar]
  23. Falzone C. J., Cavanagh J., Cowart M., Palmer A. G., 3rd, Matthews C. R., Benkovic S. J., Wright P. E. 1H, 15N and 13C resonance assignments, secondary structure, and the conformation of substrate in the binary folate complex of Escherichia coli dihydrofolate reductase. J Biomol NMR. 1994 May;4(3):349–366. doi: 10.1007/BF00179346. [DOI] [PubMed] [Google Scholar]
  24. Farrow N. A., Muhandiram R., Singer A. U., Pascal S. M., Kay C. M., Gish G., Shoelson S. E., Pawson T., Forman-Kay J. D., Kay L. E. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry. 1994 May 17;33(19):5984–6003. doi: 10.1021/bi00185a040. [DOI] [PubMed] [Google Scholar]
  25. Feeney J. NMR studies of interactions of ligands with dihydrofolate reductase. Biochem Pharmacol. 1990 Jul 1;40(1):141–152. doi: 10.1016/0006-2952(90)90189-r. [DOI] [PubMed] [Google Scholar]
  26. Gangjee A., Zaveri N., Kothare M., Queener S. F. Nonclassical 2,4-diamino-6-(aminomethyl)-5,6,7,8-tetrahydroquinazoline antifolates: synthesis and biological activities. J Med Chem. 1995 Sep 1;38(18):3660–3668. doi: 10.1021/jm00018a027. [DOI] [PubMed] [Google Scholar]
  27. Gargaro A. R., Frenkiel T. A., Nieto P. M., Birdsall B., Polshakov V. I., Morgan W. D., Feeney J. NMR detection of arginine-ligand interactions in complexes of Lactobacillus casei dihydrofolate reductase. Eur J Biochem. 1996 Jun 1;238(2):435–439. doi: 10.1111/j.1432-1033.1996.0435z.x. [DOI] [PubMed] [Google Scholar]
  28. Gargaro A. R., Soteriou A., Frenkiel T. A., Bauer C. J., Birdsall B., Polshakov V. I., Barsukov I. L., Roberts G. C., Feeney J. The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate. J Mol Biol. 1998 Mar 20;277(1):119–134. doi: 10.1006/jmbi.1997.1560. [DOI] [PubMed] [Google Scholar]
  29. Gerothanassis I. P., Barrie P. J., Birdsall B., Feeney J. 31P solid-state NMR measurements used to detect interactions between NADPH and water and to determine the ionisation state of NADPH in a protein-ligand complex subjected to low-level hydration. Eur J Biochem. 1996 Jan 15;235(1-2):262–266. doi: 10.1111/j.1432-1033.1996.00262.x. [DOI] [PubMed] [Google Scholar]
  30. Hammond S. J., Birdsall B., Searle M. S., Roberts G. C., Feeney J. Dihydrofolate reductase. 1H resonance assignments and coenzyme-induced conformational changes. J Mol Biol. 1986 Mar 5;188(1):81–97. doi: 10.1016/0022-2836(86)90483-3. [DOI] [PubMed] [Google Scholar]
  31. Hempel A., Camerman N., Camerman A. Trimetrexate: molecular structures and conformational similarities in two crystal forms. Cancer Biochem Biophys. 1988 Jul;10(1):25–30. [PubMed] [Google Scholar]
  32. Jackson R. C., Fry D. W., Boritzki T. J., Besserer J. A., Leopold W. R., Sloan B. J., Elslager E. F. Biochemical pharmacology of the lipophilic antifolate, trimetrexate. Adv Enzyme Regul. 1984;22:187–206. doi: 10.1016/0065-2571(84)90014-1. [DOI] [PubMed] [Google Scholar]
  33. Johnson J. M., Meiering E. M., Wright J. E., Pardo J., Rosowsky A., Wagner G. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase. Biochemistry. 1997 Apr 15;36(15):4399–4411. doi: 10.1021/bi963039i. [DOI] [PubMed] [Google Scholar]
  34. Kay L. E., Torchia D. A., Bax A. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry. 1989 Nov 14;28(23):8972–8979. doi: 10.1021/bi00449a003. [DOI] [PubMed] [Google Scholar]
  35. Laskowski R. A., Rullmannn J. A., MacArthur M. W., Kaptein R., Thornton J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR. 1996 Dec;8(4):477–486. doi: 10.1007/BF00228148. [DOI] [PubMed] [Google Scholar]
  36. Lewis A. J., Walz D. T. Immunopharmacology of gold. Prog Med Chem. 1982;19:1–58. doi: 10.1016/s0079-6468(08)70327-8. [DOI] [PubMed] [Google Scholar]
  37. Lin J. T., Bertino J. R. Trimetrexate: a second generation folate antagonist in clinical trial. J Clin Oncol. 1987 Dec;5(12):2032–2040. doi: 10.1200/JCO.1987.5.12.2032. [DOI] [PubMed] [Google Scholar]
  38. Lin J. T., Bertino J. R. Update on trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties. Cancer Invest. 1991;9(2):159–172. doi: 10.3109/07357909109044227. [DOI] [PubMed] [Google Scholar]
  39. Martorell G., Gradwell M. J., Birdsall B., Bauer C. J., Frenkiel T. A., Cheung H. T., Polshakov V. I., Kuyper L., Feeney J. Solution structure of bound trimethoprim in its complex with Lactobacillus casei dihydrofolate reductase. Biochemistry. 1994 Oct 18;33(41):12416–12426. doi: 10.1021/bi00207a008. [DOI] [PubMed] [Google Scholar]
  40. Matthews D. A., Bolin J. T., Burridge J. M., Filman D. J., Volz K. W., Kaufman B. T., Beddell C. R., Champness J. N., Stammers D. K., Kraut J. Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J Biol Chem. 1985 Jan 10;260(1):381–391. [PubMed] [Google Scholar]
  41. Matthews D. A., Bolin J. T., Burridge J. M., Filman D. J., Volz K. W., Kraut J. Dihydrofolate reductase. The stereochemistry of inhibitor selectivity. J Biol Chem. 1985 Jan 10;260(1):392–399. [PubMed] [Google Scholar]
  42. Morgan W. D., Birdsall B., Polshakov V. I., Sali D., Kompis I., Feeney J. Solution structure of a brodimoprim analogue in its complex with Lactobacillus casei dihydrofolate reductase. Biochemistry. 1995 Sep 19;34(37):11690–11702. doi: 10.1021/bi00037a006. [DOI] [PubMed] [Google Scholar]
  43. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991;11(4):281–296. doi: 10.1002/prot.340110407. [DOI] [PubMed] [Google Scholar]
  44. Nieto P. M., Birdsall B., Morgan W. D., Frenkiel T. A., Gargaro A. R., Feeney J. Correlated bond rotations in interactions of arginine residues with ligand carboxylate groups in protein ligand complexes. FEBS Lett. 1997 Mar 17;405(1):16–20. doi: 10.1016/s0014-5793(97)00147-6. [DOI] [PubMed] [Google Scholar]
  45. Nilges M. Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J Mol Biol. 1995 Feb 3;245(5):645–660. doi: 10.1006/jmbi.1994.0053. [DOI] [PubMed] [Google Scholar]
  46. Nilges M., Gronenborn A. M., Brünger A. T., Clore G. M. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. Protein Eng. 1988 Apr;2(1):27–38. doi: 10.1093/protein/2.1.27. [DOI] [PubMed] [Google Scholar]
  47. Polshakov V. I., Frenkiel T. A., Birdsall B., Soteriou A., Feeney J. Determination of stereospecific assignments, torsion-angle constraints, and rotamer populations in proteins using the program AngleSearch. J Magn Reson B. 1995 Jul;108(1):31–43. doi: 10.1006/jmrb.1995.1099. [DOI] [PubMed] [Google Scholar]
  48. Robert F. Trimetrexate as a single agent in patients with advanced head and neck cancer. Semin Oncol. 1988 Apr;15(2 Suppl 2):22–26. [PubMed] [Google Scholar]
  49. Sawaya M. R., Kraut J. Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry. 1997 Jan 21;36(3):586–603. doi: 10.1021/bi962337c. [DOI] [PubMed] [Google Scholar]
  50. Searle M. S., Forster M. J., Birdsall B., Roberts G. C., Feeney J., Cheung H. T., Kompis I., Geddes A. J. Dynamics of trimethoprim bound to dihydrofolate reductase. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3787–3791. doi: 10.1073/pnas.85.11.3787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Soteriou A., Carr M. D., Frenkiel T. A., McCormick J. E., Bauer C. J., Sali D., Birdsall B., Feeney J. 3D 13C/1H NMR-based assignments for side-chain resonances of Lactobacillus casei dihydrofolate reductase. Evidence for similarities between the solution and crystal structures of the enzyme. J Biomol NMR. 1993 Sep;3(5):535–546. doi: 10.1007/BF00174608. [DOI] [PubMed] [Google Scholar]
  52. Wishart D. S., Bigam C. G., Yao J., Abildgaard F., Dyson H. J., Oldfield E., Markley J. L., Sykes B. D. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995 Sep;6(2):135–140. doi: 10.1007/BF00211777. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES